Class information for:
Level 1: SOLUBLE CD30//CD30//SCD30

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
17811 581 39.2 90%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
10 3       IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL 134299
854 2             CD40//BAFF//CD40 LIGAND 11643
17811 1                   SOLUBLE CD30//CD30//SCD30 581

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 SOLUBLE CD30 authKW 1934976 8% 82% 45
2 CD30 authKW 1930652 22% 28% 130
3 SCD30 authKW 1724506 8% 75% 44
4 CD30 LIGAND authKW 773991 3% 82% 18
5 CD30L authKW 422936 2% 62% 13
6 CD153 authKW 210221 1% 100% 4
7 SOLUBLE CD30 SCD30 authKW 157666 1% 100% 3
8 CANCER BIOTHERAPY authKW 118242 1% 38% 6
9 KI 1 57 authKW 105111 0% 100% 2
10 MEMBRANE CD30 authKW 105111 0% 100% 2

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Immunology 4806 44% 0% 254
2 Transplantation 2517 14% 0% 81
3 Hematology 1000 13% 0% 77
4 Oncology 740 20% 0% 116
5 Allergy 661 5% 0% 30
6 Pathology 318 7% 0% 42
7 Medicine, Research & Experimental 166 7% 0% 43
8 Surgery 119 10% 0% 57
9 Cell Biology 92 8% 0% 49
10 Medical Laboratory Technology 35 2% 0% 9

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 IST TIPIZZAZ TISSUTALE PROBLEMI DIALISI 59121 1% 38% 3
2 AMGEN MS15 2C 52555 0% 100% 1
3 AO CITTA DELLA SALUTE E DELLA SCI 52555 0% 100% 1
4 ASL 4 AQUILA 52555 0% 100% 1
5 BEIJING TONGEN HOSP 52555 0% 100% 1
6 BETH ISRAEL DEACONESS MED HEMATOPATHOL 52555 0% 100% 1
7 BIOL MOL ESTRUTUAL 52555 0% 100% 1
8 CANC SCI TREMONA RD 52555 0% 100% 1
9 CARDIAC TRANSPLANTAT SURG SERV 52555 0% 100% 1
10 CHARTED PARTICLE THER Y 52555 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 TRANSPLANT IMMUNOLOGY 16664 3% 2% 19
2 CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 8086 3% 1% 15
3 CURRENT HEMATOLOGIC MALIGNANCY REPORTS 1505 1% 1% 3
4 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 1328 3% 0% 17
5 LEUKEMIA & LYMPHOMA 978 2% 0% 12
6 CYTOKINES AND MOLECULAR THERAPY 971 0% 2% 1
7 FUNDAMENTAL AND CLINICAL IMMUNOLOGY 889 0% 2% 1
8 HLA 819 0% 2% 1
9 TRANSPLANTATION 800 3% 0% 17
10 JOURNAL OF IMMUNOLOGY 731 5% 0% 28

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 SOLUBLE CD30 1934976 8% 82% 45 Search SOLUBLE+CD30 Search SOLUBLE+CD30
2 CD30 1930652 22% 28% 130 Search CD30 Search CD30
3 SCD30 1724506 8% 75% 44 Search SCD30 Search SCD30
4 CD30 LIGAND 773991 3% 82% 18 Search CD30+LIGAND Search CD30+LIGAND
5 CD30L 422936 2% 62% 13 Search CD30L Search CD30L
6 CD153 210221 1% 100% 4 Search CD153 Search CD153
7 SOLUBLE CD30 SCD30 157666 1% 100% 3 Search SOLUBLE+CD30+SCD30 Search SOLUBLE+CD30+SCD30
8 CANCER BIOTHERAPY 118242 1% 38% 6 Search CANCER+BIOTHERAPY Search CANCER+BIOTHERAPY
9 KI 1 57 105111 0% 100% 2 Search KI+1+57 Search KI+1+57
10 MEMBRANE CD30 105111 0% 100% 2 Search MEMBRANE+CD30 Search MEMBRANE+CD30

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 OFLAZOGLU, E , GREWAL, IS , GERBER, H , (2009) TARGETING CD30/CD30L IN ONCOLOGY AND AUTOIMMUNE AND INFLAMMATORY DISEASES.THERAPEUTIC TARGETS OF THE TNF SUPERFAMILY. VOL. 647. ISSUE . P. 174-185 63 73% 30
2 KENNEDY, MK , WILLIS, CR , ARMITAGE, RJ , (2006) DECIPHERING CD30 LIGAND BIOLOGY AND ITS ROLE IN HUMORAL IMMUNITY.IMMUNOLOGY. VOL. 118. ISSUE 2. P. 143-152 60 76% 67
3 DEUTSCH, YE , TADMOR, T , PODACK, ER , ROSENBLATT, JD , (2011) CD30: AN IMPORTANT NEW TARGET IN HEMATOLOGIC MALIGNANCIES.LEUKEMIA & LYMPHOMA. VOL. 52. ISSUE 9. P. 1641 -1654 60 55% 35
4 SCHLAF, G , ALTERMANN, WW , ROTHHOFF, A , SELIGER, B , (2007) SOLUBLE CD30 SERUM LEVEL - AN ADEQUATE MARKER FOR ALLOGRAFT REJECTION OF SOLID ORGANS?.HISTOLOGY AND HISTOPATHOLOGY. VOL. 22. ISSUE 11. P. 1269-1279 49 79% 13
5 MUTA, H , PODACK, ER , (2013) CD30: FROM BASIC RESEARCH TO CANCER THERAPY.IMMUNOLOGIC RESEARCH. VOL. 57. ISSUE 1-3. P. 151-158 44 72% 11
6 OPAT, S , GASTON, JSH , (2001) CD30 : CD30 LIGAND INTERACTIONS IN THE IMMUNE RESPONSE.AUTOIMMUNITY. VOL. 33. ISSUE 1. P. 45-60 84 55% 3
7 TARKOWSKI, M , (2003) EXPRESSION AND A ROLE OF CD30 IN REGULATION OF T-CELL ACTIVITY.CURRENT OPINION IN HEMATOLOGY. VOL. 10. ISSUE 4. P. 267-271 49 80% 46
8 HORIE, R , WATANABE, T , (1998) CD30: EXPRESSION AND FUNCTION IN HEALTH AND DISEASE.SEMINARS IN IMMUNOLOGY. VOL. 10. ISSUE 6. P. 457 -470 68 58% 146
9 CHIARLE, R , PODDA, A , PROLLA, G , GONG, J , THORBECKE, GJ , INGHIRAMI, G , (1999) CD30 IN NORMAL AND NEOPLASTIC CELLS.CLINICAL IMMUNOLOGY. VOL. 90. ISSUE 2. P. 157-164 62 64% 96
10 BENGTSSON, A , (2001) THE ROLE OF CD30 IN ATOPIC DISEASE.ALLERGY. VOL. 56. ISSUE 7. P. 593 -603 60 64% 37

Classes with closest relation at Level 1


Rank Class id link
1 7850 ANAPLASTIC LARGE CELL LYMPHOMA//LYMPHOMATOID PAPULOSIS//CD30
2 22211 IMMUKNOW//IMMUNE MONITORING//PHARMACODYNAMIC MONITORING
3 17952 TRAF4//TRAF6//TRAF2
4 22811 CD70//CD27//SIVA 1
5 2610 HODGKINS DISEASE//NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA//HODGKIN LYMPHOMA
6 35492 LAG 3//LYMPHOCYTE ACTIVATION GENE 3//CD223
7 8384 4 1BB//OX40//CD137
8 8274 INTERLEUKIN 4//IL 4//IGE SYNTHESIS
9 11281 ANTIBODY DRUG CONJUGATE//GEMTUZUMAB OZOGAMICIN//MYLOTARG
10 996 HODGKINS DISEASE//HODGKIN LYMPHOMA//HODGKINS LYMPHOMA

Go to start page